ArticleBMC infectious diseases2024

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.

Namareq F Aldardeer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.